Gadolinium deposition in nephrogenic fibrosing dermopathy.
about
Enhanced MRI relaxivity of Gd(3+) -based contrast agents geometrically confined within porous nanoconstructs.Interaction of Gd-DTPA with phosphate and phosphite: toward the reaction intermediate in nephrogenic systemic fibrosis.Scleroderma MimickersBiodistribution of gadolinium-based contrast agents, including gadolinium deposition.Nephrogenic systemic fibrosis in liver disease: a systematic review.Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.Nephrogenic systemic fibrosis, in patients with end-stage kidney disease on dialysis, in the greater Auckland region, from 2000-2006.Novel sorbents for removal of gadolinium-based contrast agents in sorbent dialysis and hemoperfusion: preventive approaches to nephrogenic systemic fibrosis.Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.DW-MRI of the urogenital tract: applications in oncology.Type of MRI contrast, tissue gadolinium, and fibrosis.Substitution of gadolinium ethylenediaminetetraacetate with phosphites: towards gadolinium deposit in nephrogenic systemic fibrosis.Responses of human skin in organ culture and human skin fibroblasts to a gadolinium-based MRI contrast agent: comparison of skin from patients with end-stage renal disease and skin from healthy subjects.Measurement of absolute arterial cerebral blood volume in human brain without using a contrast agent.Improved quantitative (19) F MR molecular imaging with flip angle calibration and B1 -mapping compensationStrategies for the preparation of bifunctional gadolinium(III) chelators.Total gadolinium tissue deposition and skin structural findings following the administration of structurally different gadolinium chelates in healthy and ovariectomized female rats.Revisiting the risks of MRI with Gadolinium based contrast agents-review of literature and guidelines.Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation.Changing trends in a decade of vascular radiology-the impact of technical developments of non-invasive techniques on vascular imaging.Diagnostic Utility of Diffusion-weighted Magnetic Resonance Imaging in Differentiating Small Solid Renal Tumors (≤ 4 cm) at 3.0T Magnetic Resonance Imaging.Gadolinium and nephrogenic systemic fibrosis: time to tighten practice.Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.Myelin imaging compound (MIC) enhanced magnetic resonance imaging of myelination.Gadolinium is not the only trigger for nephrogenic systemic fibrosis: insights from two cases and review of the recent literature.Nephrogenic systemic fibrosis: a nephrologist's perspective.Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis.Gadolinium and nephrogenic systemic fibrosis: association or causation.Gadolinium - is it to blame?Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 casesAssociation of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis.Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis.High signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification.Renal artery stenosis: pathophysiology and treatment.Nephrogenic systemic fibrosis risk and liver disease.Nanoparticles: small and mighty.Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review.Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed casesUpdate on nephrogenic systemic fibrosis: are we making progress?
P2860
Q30568297-FFDA0560-C7B7-46B2-93EB-700C2C51D838Q31048535-256958CA-E616-4E85-8801-9938B86F89E2Q33625658-96D42F5D-A694-407D-ABE4-77274832DE53Q33655413-AA393AC8-CD71-495F-BED0-EC7714D517EDQ33748364-F7E98842-F876-40CE-B85F-9CBF137208F3Q33768695-6F36E60B-5EE8-4A99-89DE-75227938108FQ33778292-E625B4EE-D5BF-48AD-A4D5-5D6E2CDA3810Q33805280-B8050D0E-6521-4BAE-A237-1BD8235F5AE4Q33822402-CAF17972-57B7-4869-BD2A-685896D4CC39Q33847006-8FCE9FC7-CBC8-421E-A26D-C8CB6E6B77D2Q34256443-6FC135A6-9C59-4DFB-98F0-A38014CD85F4Q34602036-900CED7D-A13B-4AC3-98A4-5046F08CB290Q35019353-E3388193-C2F3-42AC-A2EC-BE31607D0B4DQ35187986-47D60085-201C-41C4-80AC-A50D9C4DE639Q35331927-0F553405-594A-4402-80C2-32246B88B577Q35642484-7CF5F579-0164-419E-BFED-423701E9DCD9Q35777941-1DDA2476-4155-4A9E-AA41-46281969A26BQ36027601-F5DEAE26-3C00-42AC-965C-82AE7CF6EFDCQ36059081-6FC9CFFA-CC69-481E-A9A2-82CD5F8803E0Q36063298-3BD63B49-D0FF-489D-B111-5A90FA231169Q36236554-4FC75454-E889-4134-AB51-0FBFD7F5DF8CQ36523261-ADB2EB50-5086-4A0D-9EE4-BEEB283284DBQ36538610-7E04BE5E-4928-495E-9D15-CBBA3AD5C870Q36791108-160982F9-6D3E-40A8-9929-F3ED99078B07Q36800158-B8B62008-6D00-4E17-82AA-CB693D86FB86Q36915537-D56E92D3-F7BA-45D5-A105-9352A6ADD3C3Q36952499-B9263063-A963-4088-B6D0-1BAA2DD0A535Q36985258-AC3B2662-69EE-4AC0-B6CC-FA5219A7E57EQ37067538-108644E7-BE09-4619-A693-3FE55BAA0174Q37133328-E35F54E2-A99C-497C-8379-009A0ADFA5A9Q37145493-43BC7112-4127-4CBF-BF50-E571EE0DFBFDQ37219177-251CD946-901B-47BF-BD22-889EF8134EDBQ37308825-EAFD188D-5875-45DE-8124-BF743C4E7A17Q37344053-A9D868F7-DF7D-427A-A090-A5C9FC4E111BQ37629846-433EF23B-7B25-4C4B-8201-804C5B71D4EFQ37694083-CD0D868B-05F5-4E43-BE50-CE25A0B76742Q37845900-74B56823-EC83-48CA-A953-D178E3027B9AQ37858286-9EA08046-F449-470F-8D95-61EE46021F65Q37875688-39A6C0C2-A22C-4CAB-907D-1C003F2C2D4DQ37877286-77DAF531-FEC4-4467-8ED5-B446DBD31DFD
P2860
Gadolinium deposition in nephrogenic fibrosing dermopathy.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Gadolinium deposition in nephrogenic fibrosing dermopathy.
@ast
Gadolinium deposition in nephrogenic fibrosing dermopathy.
@en
Gadolinium deposition in nephrogenic fibrosing dermopathy.
@nl
type
label
Gadolinium deposition in nephrogenic fibrosing dermopathy.
@ast
Gadolinium deposition in nephrogenic fibrosing dermopathy.
@en
Gadolinium deposition in nephrogenic fibrosing dermopathy.
@nl
prefLabel
Gadolinium deposition in nephrogenic fibrosing dermopathy.
@ast
Gadolinium deposition in nephrogenic fibrosing dermopathy.
@en
Gadolinium deposition in nephrogenic fibrosing dermopathy.
@nl
P2093
P1476
Gadolinium deposition in nephrogenic fibrosing dermopathy.
@en
P2093
Alan S Boyd
Jerrold L Abraham
John A Zic
P356
10.1016/J.JAAD.2006.10.048
P407
P577
2006-11-15T00:00:00Z